BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
11/6/2020 9:07:39 AM | Browse: 348 | Download: 609
|
Received |
|
2020-07-25 07:25 |
|
Peer-Review Started |
|
2020-07-25 07:26 |
|
To Make the First Decision |
|
|
|
Return for Revision |
|
2020-09-24 20:04 |
|
Revised |
|
2020-09-30 04:52 |
|
Second Decision |
|
2020-10-19 08:00 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Company Editor-in-Chief |
|
2020-10-20 03:41 |
|
Articles in Press |
|
2020-10-20 03:41 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2020-11-03 06:41 |
|
Publish the Manuscript Online |
|
2020-11-06 09:07 |
ISSN |
2307-8960 (online) |
Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
Copyright |
© The Author(s) 2020. Published by Baishideng Publishing Group Inc. All rights reserved. |
Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
Website |
http://www.wjgnet.com |
Category |
Oncology |
Manuscript Type |
Correction |
Article Title |
Erratum: Author’s Affiliation Correction. Type II human epidermal growth factor receptor heterogeneity is a poor prognosticator for type II human epidermal growth factor receptor positive gastric cancer (World J Clin Cases 2019; Aug 6; 7 (15): 1964-1977)
|
Manuscript Source |
Unsolicited Manuscript |
All Author List |
Akio Kaito, Takeshi Kuwata, Masanori Tokunaga, Kohei Shitara, Reo Sato, Tetsuo Akimoto and Takahiro Kinoshita |
ORCID |
|
Funding Agency and Grant Number |
|
Corresponding Author |
Takeshi Kuwata, MD, PhD, Doctor, Department of Pathology and Clinical Laboratories, National Cancer Center Hospital East, 6-5-1, Kashiwano-ha, Kashiwa 277-8577, Japan. tkuwata@east.ncc.go.jp |
Key Words |
Correction; ; ; ; ; |
Core Tip |
This manuscript is an author's affiliation correction for type II human epidermal growth factor receptor heterogeneity is a poor prognosticator for type II human epidermal growth factor receptor positive gastric cancer (World J Clin Cases 2019; Aug 6; 7 (15): 1964-1977) |
Publish Date |
2020-11-06 09:07 |
Citation |
Kaito A, Kuwata T, Tokunaga M, Shitara K, Sato R, Akimoto T, Kinoshita T. Erratum: Author’s Affiliation Correction. Type II human epidermal growth factor receptor heterogeneity is a poor prognosticator for type II human epidermal growth factor receptor positive gastric cancer (World J Clin Cases 2019; Aug 6; 7 (15): 1964-1977). World J Clin Cases 2020; 8(21): 5494-5495 |
URL |
https://www.wjgnet.com/2307-8960/full/v8/i21/5494.htm |
DOI |
https://dx.doi.org/10.12998/wjcc.v8.i21.5494 |
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345